Markman, Maurie <br/><br/>
Differences between a drug regimen employed in early phase 1 trials and the subsequent use of the agent in routine oncologic practice: a note of caution.  [electronic resource] 

 -  Cancer  Oct 2007 
 - 1644-7 p.  digital 
<br/><br/> Publication Type: Editorial 
<br/><br/><label>ISSN: </label>0008-543X 
<br/><br/><label>Standard No.: </label>10.1002/cncr.22967  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antineoplastic Agents--therapeutic use<br/>Clinical Trials, Phase I as Topic<br/>Humans<br/>Medical Oncology<br/>Neoplasms--drug therapy